FINNENCE ▪ THE WIRE FILE
THE WIRE · № 70646
News▲ Bullish
Biohaven Enters Strategic Licensing Agreement with Ono Pharma for Extracellular IgG Degraders in Japan and Select Asian Regions, Lead Candidate BHV-1300 in Phase 3 for Graves' Disease
KINDNews
DIRECTION▲ Bullish
SOURCES1
ENTITIES2
STORY SIZESTANDALONE
FIRST SEEN2026-10-08 08:00 UTC
LAST UPDATE2026-10-08 08:00 UTC
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
Biohaven's licensing deal with Ono brings up to $100M near-term and validates its IgG degrader pipeline.
Biohaven monetizes IgG degrader pipeline
CATALYST TO WATCH
Phase 3 Graves' disease data
MAIN RISK
Milestone payments depend on trial success
FULL DISPATCH
Ono will obtain an exclusive license to develop and commercialize Biohaven's MoDE pan IgG degraders in Japan, South Korea, Taiwan, and ASEAN member states, led by BHV-1300 and including certain next-generation follow-on IgG degraders. Biohaven will receive up to $100 million in near-term...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
CONTEXTJapan
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
←CORRELATIONshares Japan
CPI | Japan Antitrust Regulator Probes Four Major Brewers2026-10-07 18:33 UTC
CPI | Japan Antitrust Regulator Probes Four Major Brewers2026-10-07 18:33 UTC
←CORRELATIONshares Healthcare
Wally Raises $25 Million to Scale Nation's Fastest-Growing Oral Care Membership with Unlimited Cleanings & Diagnostics2026-10-07 19:35 UTC
Wally Raises $25 Million to Scale Nation's Fastest-Growing Oral Care Membership with Unlimited Cleanings & Diagnostics2026-10-07 19:35 UTC
←CORRELATIONshares Healthcare
Medical device maker Centinel Spine discloses revenue rise in US IPO filing2026-10-07 21:13 UTC
Medical device maker Centinel Spine discloses revenue rise in US IPO filing2026-10-07 21:13 UTC
←CORRELATIONshares Healthcare
CNTL IPO News - Spinal implant developer Centinel Spine files for a $100 million IPO2026-10-07 21:24 UTC
CNTL IPO News - Spinal implant developer Centinel Spine files for a $100 million IPO2026-10-07 21:24 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.